Tributyrin for progressive supranuclear palsy
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial tests a supplement called tributyrin to see if it can help people with progressive supranuclear palsy (PSP), a condition that affects movement and balance. The study is done virtually, so you can participate from home with a caregiver's help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older.
- You have been diagnosed with PSP-Richardson syndrome, which includes trouble looking up or down and falls or a tendency to fall within the last 3 years.
- You have access to the internet and a webcam for virtual visits.
- You have a caregiver who can support you during the study.
- You do not have significant stomach or gut problems, uncontrolled medical conditions, or take certain medications for bladder or other issues.
- You are not pregnant, nursing, or able to become pregnant, and you do not have suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a supplement called tributyrin to see if it can help with thinking and memory problems in people with Parkinson's disease. You may be able to join if you have both Parkinson's and mild cognitive impairment or dementia.
This trial tests potential new treatments for progressive supranuclear palsy (PSP), a brain disorder affecting movement, balance, and thinking. It aims to see if these treatments are safe and slow the disease. You may be able to join if you have a specific type of PSP and are in fairly good health.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
This study tests whether a drug called butylphthalide can safely help people with multiple system atrophy (MSA), a rare brain disorder that affects movement and automatic body functions like blood pressure. Participating may help slow the progression of symptoms and improve quality of life.
This study tests how well remote monitoring tools, like wearable devices, can track symptoms in people with movement disorders like PSP, Parkinson's disease, or MSA. The goal is to see if these tools can help doctors better understand how the disease progresses from home.
Hear when a new Multiple System Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.